HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhancement of XPG mRNA transcription by human interferon-beta in Cockayne syndrome cells with complementation group B.

Abstract
Human interferon-beta (HuIFN-beta) confers UV-refractoriness in association with increased DNA repair capacity to human cells. We examined the modulation of XPG gene expression by HuIFN-beta in UV-sensitive cells from Cockayne syndrome complementation B (CSB), xeroderma pigmentosum complementation A (XPA) and normal control cells. Northern blot analysis revealed that XPG mRNA was more extensively transcribed in CSB cells treated with HuIFN-beta than in those without HuIFN-beta treatment. XPG mRNA from XPA cells and normal control cells was not markedly transcribed by HuIFN-beta treatment compared to that from CSB cells. The findings suggested that different mechanisms of UV-refractoriness by HuIFN-beta exist between CS and XP.
AuthorsY Suzuki, K Sugita, N Suzuki, K Kita, Y Higuchi, A Yamaura, Y Kohno
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 3 Issue 1 Pg. 87-9 (Jan 1999) ISSN: 1107-3756 [Print] Greece
PMID9864391 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA excision repair protein ERCC-5
  • DNA-Binding Proteins
  • Nuclear Proteins
  • RNA, Messenger
  • Transcription Factors
  • RNA
  • Interferon-beta
  • Endonucleases
Topics
  • Blotting, Northern
  • Cell Line, Transformed
  • Cockayne Syndrome (genetics, pathology)
  • DNA-Binding Proteins (genetics)
  • Endonucleases
  • Humans
  • Interferon-beta (pharmacology)
  • Nuclear Proteins
  • RNA (analysis, genetics)
  • RNA, Messenger (genetics)
  • Transcription Factors
  • Transcription, Genetic (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: